Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

NIPRO VASCULAR CORPORATION (formerly Goodman Co., Ltd.)

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

NIPRO VASCULAR CORPORATION (formerly Goodman Co., Ltd.)

Regulatory records
3
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 3 FDA records to the applicant name NIPRO VASCULAR CORPORATION (formerly Goodman Co., Ltd.). 3 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Jul 22, 2026 to Jul 22, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code NWX appears in 3 of the 3 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P230026, with 3 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 5f Kdx Nagoya Sakae Bldg., 4-5-3, Sakae, Naka-Ku, Nagoya. Recorded on P230026/S003, decision dated Jul 22, 2026.

Changes described in PMA records

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.